|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1995-3-16
|
|
pubmed:abstractText |
The increasing incidence of prostate cancer creates complex issues in health care management and cost containment. There is a need to evaluate serial measurements of prostate-specific antigen (PSA) as a marker for long-term risk of clinically important prostate cancer (stages B through D).
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0027-8874
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
87
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
354-60
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:7531773-Adult,
pubmed-meshheading:7531773-African Americans,
pubmed-meshheading:7531773-Age Factors,
pubmed-meshheading:7531773-Aged,
pubmed-meshheading:7531773-Aged, 80 and over,
pubmed-meshheading:7531773-Case-Control Studies,
pubmed-meshheading:7531773-European Continental Ancestry Group,
pubmed-meshheading:7531773-Humans,
pubmed-meshheading:7531773-Male,
pubmed-meshheading:7531773-Middle Aged,
pubmed-meshheading:7531773-Predictive Value of Tests,
pubmed-meshheading:7531773-Prostate-Specific Antigen,
pubmed-meshheading:7531773-Prostatic Neoplasms,
pubmed-meshheading:7531773-Regression Analysis,
pubmed-meshheading:7531773-Retrospective Studies
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Prostate-specific antigen as predictor of prostate cancer in black men and white men.
|
|
pubmed:affiliation |
Department of Health Research and Policy, Stanford University School of Medicine, Calif. 94305-5092.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
